GKB Ophthalmics: Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter and half…
GKB Ophthalmics (GKB) filed a disclosure titled "Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026". The company is valued at about ₹34.93 crore.
What happened
GKB Ophthalmics (GKB) filed a disclosure with the exchanges on 12 November 2026 at 05:29 PM titled "Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026".
Company snapshot
GKB Ophthalmics is a micro-cap company, with a market value of about ₹34.93 crore.
The stock last traded at ₹69.29, against a 52-week range of ₹55.01–₹88.4 (21.6% below the high).
Before this filing the shares had moved +0.2% over the month and −31.7% over three months. Average daily turnover over the last 20 sessions was about ₹0.03 crore.
Promoters held 51.15% at the end of Q1 FY27, up 0.02% points from the previous quarter. Foreign institutions owned 1.79% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 9 | -2.1 | -4.25 |
| Q2 FY26 | 6 | -0.5 | -1.04 |
| Q3 FY26 | 4 | 1 | 1.95 |
| Q4 FY26 | 6 | -1.9 | -3.74 |
| Q1 FY27 | 6 | -0.5 | -1 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Market-wide, 11,631 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.